Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can get Mounjaro on prescription in the UK. It is a prescription-only medicine (a POM), which means a licensed prescriber must assess you before it can be legally supplied. That assessment can happen through your NHS GP if you meet the current eligibility criteria, or through a regulated private pharmacy without a referral or waiting list. Mounjaro (tirzepatide) holds a full UK licence for weight management in adults with a BMI of 30 or above, or 27 and above where a weight-related health condition is present, and every legal prescription follows a clinical review of your individual circumstances.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is not a formality. Mounjaro is classified as a Prescription-Only Medicine under the Human Medicines Regulations 2012, which means it cannot be legally sold or supplied without a valid prescription from a registered prescriber. That rule exists because tirzepatide is a clinically active medicine (it lowers appetite, slows gastric emptying, and affects blood-sugar regulation) and those effects need to be matched to the right person. There is no legal shortcut: any seller offering Mounjaro without a prescription is breaking UK medicines law, and the MHRA has repeatedly warned about counterfeit pens sold via social media that have caused harm. The prescription requirement is the protection, not the obstacle.
One misconception worth clearing up: people sometimes assume a prescription for Mounjaro is simply a rubber stamp. In practice, the clinical assessment looks at your BMI, your weight-related conditions, your current medicines, your medical history, and whether tirzepatide is safe alongside everything else you take. For women using oral contraceptives, for instance, NHS England guidance advises adding a barrier method for the first four weeks of treatment and after each dose increase, because absorption of the pill can be affected. That kind of nuance only surfaces through a proper clinical review.
Getting Mounjaro on prescription through the NHS is possible, but access is tightly phased. NICE recommended tirzepatide for NHS use in December 2024 (TA1026), and NHS England is rolling it out in stages. As of summer 2026, the first cohort (adults with a BMI of 40 or above and four or more specific weight-related conditions) became eligible. From around June 2026, adults with a BMI between 35 and 39.9 and four or more of those conditions joined the programme. Lower BMI thresholds apply for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds. Future phases will extend access further, though timelines shift.
From 1 April 2026, GP practices may prescribe tirzepatide under the updated GP contract, but participation varies by practice and area. Every NHS patient must also take part in a structured diet and activity support programme. Meeting the criteria on paper does not guarantee a prescription quickly; your GP decides whether the clinical picture fits. For people who do not meet the current NHS thresholds, or who would rather not wait, a private prescription is the alternative. You can read more about the NHS rollout on our NHS Mounjaro access page.
A private prescription route removes the referral requirement and the phased eligibility thresholds, but it does not remove the clinical assessment. At a regulated online pharmacy, you complete a detailed consultation about your weight, medical history, current medicines, and health conditions. A GPhC-registered Independent Prescriber (a real clinician, not an automated system) reviews your answers and decides whether tirzepatide is appropriate. At nume, that review happens the same day.
The licensed eligibility criteria for a private prescription follow the medicine's UK licence: BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Your BMI alone is never the whole picture; the prescriber weighs your full clinical situation. If Mounjaro is not the right fit, the prescriber will say so. For a full look at what a private prescription pathway involves, our Mounjaro prescription guide covers each step in detail, and our treatment page explains what is included in the price.
If you are comparing your options before deciding, it is worth understanding exactly why Mounjaro is prescription-only and what that means for where you buy it safely. Pricing context matters too: since Eli Lilly raised UK list prices in September 2025, private Mounjaro has typically ranged from around £149 to £375 per month depending on dose and provider, and what that price includes varies considerably, consultation fees, aftercare and delivery are not always bundled in. Our guide to buying Mounjaro breaks down what to check before committing to any provider.
The key marker of a legitimate service is that it cannot supply Mounjaro without a proper clinical assessment. Check that the pharmacy appears on the GPhC register before sharing any health information or making a payment. A registered pharmacy has a premises registration number you can verify in seconds. Red flags include sellers offering Mounjaro at prices well below the market range, services that ask no clinical questions, and anything marketed through social media without a clear regulated pharmacy behind it.
The MHRA's enforcement activity through 2025 resulted in around 20 million doses of illegally traded weight-loss medicines (worth roughly £45 million) being seized, including the first UK raid of a site manufacturing counterfeit tirzepatide pens. Fake pens have in some cases contained insulin rather than tirzepatide, which is dangerous. Reporting suspect sellers through the Yellow Card scheme helps the MHRA act quickly. For more detail on spotting a legitimate route, our page on buying Mounjaro without going through a doctor explains what the rules actually require and why they are there.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.